Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, 77030, USA.
HPB (Oxford). 2012 Aug;14(8):506-13. doi: 10.1111/j.1477-2574.2012.00479.x. Epub 2012 May 15.
Historically, liver surgeons have withheld venous thromboembolism (VTE) chemoprophylaxis due to perceived postoperative bleeding risk and theorized protective anticoagulation effects of a hepatectomy. The relationships between extent of hepatectomy, postoperative VTE and bleeding events were evaluated using the National Surgical Quality Improvement Program (NSQIP) database.
From 2005 to 2009, all elective open hepatectomies were identified. Factors associated with 30-day rates of VTE, postoperative transfusions and returns to the operating room (ROR), were analysed.
The analysis included 5651 hepatectomies with 3376 (59.7%) partial, 585 (10.4%) left, 1134 (20.1%) right, and 556 (9.8%) extended. Complications included deep vein thrombosis (DVT) (1.93%), pulmonary embolism (PE) (1.31%), venous thromboembolism (VTE) (2.88%), postoperative transfusion (0.76%) and ROR with transfusion (0.44%). VTE increased with magnitude of hepatectomy (partial 2.13%, left 2.05%, right 4.15%, extended 5.76%; P < 0.001) and outnumbered bleeding events (P < 0.001). Other factors independently associated with VTE were aspartate aminotransferase (AST) ≥27 (P= 0.022), American Society of Anesthesiologists (ASA) class ≥3 (P < 0.001), operative time >222 min (P= 0.043), organ space infection (P < 0.001) and length of hospital stay ≥7 days (P= 0.004). VTE resulted in 30-day mortality of 7.4% vs. 2.3% with no VTE (P= 0.001).
Contrary to the belief that transient postoperative liver insufficiency is protective, VTE increases with extent of hepatectomy. VTE exceeds major bleeding events and is strongly associated with mortality. These data support routine post-hepatectomy VTE chemoprophylaxis.
由于术后出血风险的考虑,以及肝切除术可能具有的抗凝保护作用,传统上肝外科医生会避免对静脉血栓栓塞症(VTE)进行预防性抗凝治疗。本研究利用国家外科质量改进计划(NSQIP)数据库,评估肝切除术的范围、术后 VTE 及出血事件之间的关系。
本研究纳入了 2005 年至 2009 年间所有择期开腹肝切除术患者。分析了术后 30 天内 VTE、输血和再次手术(ROR)的发生率与相关因素的关系。
本研究共纳入 5651 例肝切除术患者,其中 3376 例(59.7%)为部分肝切除术,585 例(10.4%)为左半肝切除术,1134 例(20.1%)为右半肝切除术,556 例(9.8%)为扩大肝切除术。并发症包括深静脉血栓形成(DVT)(1.93%)、肺栓塞(PE)(1.31%)、VTE(2.88%)、术后输血(0.76%)和输血后 ROR(0.44%)。VTE 的发生率随着肝切除术范围的扩大而增加(部分肝切除术 2.13%,左半肝切除术 2.05%,右半肝切除术 4.15%,扩大肝切除术 5.76%;P<0.001),并且超过了出血事件的发生率(P<0.001)。其他与 VTE 相关的独立因素包括天冬氨酸氨基转移酶(AST)≥27(P=0.022)、美国麻醉医师协会(ASA)分级≥3(P<0.001)、手术时间>222 分钟(P=0.043)、器官间隙感染(P<0.001)和住院时间≥7 天(P=0.004)。VTE 患者的 30 天死亡率为 7.4%,无 VTE 患者的死亡率为 2.3%(P=0.001)。
与术后短暂性肝功能不全具有保护作用的观点相反,VTE 的发生与肝切除术的范围呈正相关。VTE 超过了大出血事件,与死亡率密切相关。这些数据支持常规的肝切除术后 VTE 化学预防。